To include your compound in the COVID-19 Resource Center, submit it here.

Genentech meets Street EPS

DNA after market close reported third quarter EPS of $0.23, in line with the Street's estimate, and $0.03 (15%) above the $0.20 EPS

Read the full 237 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE